We are live on ! Find out more
SO

STRS Ohio Portfolio holdings

AUM $25.2B
1-Year Est. Return 30.31%
This Fund
S&P 500
This Quarter Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
Cap. Flow
-$22.2M
Cap. Flow %
-0.1%
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176

Top Buys

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$74.9M
2
KEYS icon
Keysight
KEYS
+$52.1M
3
MRK icon
Merck
MRK
+$40.9M
4
ABBV icon
AbbVie
ABBV
+$38.6M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$37.7M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$104M
2
MTCH icon
Match Group
MTCH
+$48.9M
3
TDG icon
TransDigm Group
TDG
+$43.4M
4
SYK icon
Stryker
SYK
+$43.1M
5
JNJ icon
Johnson & Johnson
JNJ
+$42.5M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Financials 14.31%
3 Healthcare 13.92%
4 Consumer Discretionary 9.62%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSBR icon
2051
Champions Oncology
CSBR
$85.1M
$18K ﹤0.01%
+1,900
New +$16.2K
LOVE icon
2052
LoveSac
LOVE
$239M
$18K ﹤0.01%
+700
New +$10.6K
PSN icon
2053
Parsons
PSN
$6.28B
$18K ﹤0.01%
+500
New +$18.8K
TELA icon
2054
TELA Bio
TELA
$30.9M
$18K ﹤0.01%
+1,400
New +$18.4K
URBN icon
2055
Urban Outfitters
URBN
$5.99B
$18K ﹤0.01%
1,200
-23,408
-95% -$401K
VRCA icon
2056
Verrica Pharmaceuticals
VRCA
$86.2M
$18K ﹤0.01%
170
ATXI
2057
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$18K ﹤0.01%
+2
New +$22.6K
LOGC
2058
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$18K ﹤0.01%
2,200
HGV icon
2059
Hilton Grand Vacations
HGV
$3.84B
$17K ﹤0.01%
900
-26,603
-97% -$525K
MLSS icon
2060
Milestone Scientific
MLSS
$34.5M
$17K ﹤0.01%
+9,000
New +$16.5K
RES icon
2061
RPC Inc
RES
$1.24B
$17K ﹤0.01%
+5,600
New +$17.1K
RVLP
2062
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$17K ﹤0.01%
2,600
CLR
2063
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$17K ﹤0.01%
999
PAGP icon
2064
Plains GP Holdings
PAGP
$5.23B
$16K ﹤0.01%
1,842
SNFCA icon
2065
Security National Financial
SNFCA
$247M
$16K ﹤0.01%
+3,297
New +$14.3K
VERO
2066
DELISTED
Venus Concept
VERO
$16K ﹤0.01%
+28
New +$17.9K
PTRS
2067
DELISTED
Partners Bancorp Common Stock
PTRS
$16K ﹤0.01%
+2,500
New +$17.4K
TYME
2068
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$16K ﹤0.01%
12,300
CEMI
2069
DELISTED
Chembio diagnostics, Inc.
CEMI
$16K ﹤0.01%
+5,000
New +$47.5K
ALRS icon
2070
Alerus Financial
ALRS
$822M
$15K ﹤0.01%
800
ETNB
2071
DELISTED
89bio
ETNB
$15K ﹤0.01%
800
NMRD
2072
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$15K ﹤0.01%
+1,700
New +$12.1K
ARLO icon
2073
Arlo Technologies
ARLO
$1.4B
$14K ﹤0.01%
+5,500
New +$13.3K
COTY icon
2074
Coty
COTY
$2.33B
$14K ﹤0.01%
3,344
-60,048
-95% -$291K
TARA icon
2075
Protara Therapeutics
TARA
$226M
$14K ﹤0.01%
+500
New +$15.5K

Similar funds

STRS Ohio's Q2 2020 Portfolio in Review

As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
  • STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
  • STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
  • STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
  • STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
  • STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
  • STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.

Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.